Flow Traders U.S. LLC Astrazeneca PLC Transaction History

Flow Traders U.S. LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $1.98 Million - $2.39 Million	29,608 Added 334.1%	38,470 $3 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $220,501 - $251,356	3,613 Added 68.83%	8,862 $600,000
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $324,860 - $363,650	5,249 New	5,249 $354,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $6,222 - $7,469	-105 Reduced 3.35%	3,034 $200,000
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $343,235 - $413,459	-6,160 Reduced 66.24%	3,139 $208,000
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $502,331 - $593,555	9,299 New	9,299 $542,000
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $240,719 - $272,820	-6,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $38,957 - $43,555	1,045 Added 21.09%	6,000 $248,000
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $175,852 - $213,164	4,955 New	4,955 $200,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Flow Traders U.S. LLC, based on Form 13F filings with the SEC.

Stay updated on Flow Traders U.S. LLC with notifications on news.